Risk of thrombolysis-associated intracerebral hemorrhage: The need to compare apples with apples

被引：5

作者：

Khatri, P ^{[1
]}

Broderick, JP

Pancioli, AM

机构：

[1] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45221 USA

[2] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA

来源：

STROKE | 2005年 / 36卷 / 06期

关键词：

D O I：

10.1161/01.STR.0000166008.72738.fd

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1109 / 1110

页数：2

共 9 条

[1]

Assessment of the Safety and Efficacy of a New Thrombolytic Investigators, 1999, LANCET, V354, P716

[2] Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke [J].

Brott, T ;

Broderick, J ;

Kothari, R ;

ODonoghue, M ;

Barsan, W ;

Tomsick, T ;

Spilker, J ;

Miller, R ;

Sauerbeck, L ;

Farrell, J ;

Kelly, J ;

Perkins, T ;

Miller, R ;

McDonald, T ;

Rorick, M ;

Hickey, C ;

Armitage, J ;

Perry, C ;

Thalinger, K ;

Rhude, R ;

Schill, J ;

Becker, PS ;

Heath, RS ;

Adams, D ;

Reed, R ;

Klei, M ;

Hughes, A ;

Anthony, J ;

Baudendistel, D ;

Zadicoff, C ;

Rymer, M ;

Bettinger, I ;

Laubinger, P ;

Schmerler, M ;

Meiros, G ;

Lyden, P ;

Dunford, J ;

Zivin, J ;

Rapp, K ;

Babcock, T ;

Daum, P ;

Persona, D ;

Brody, M ;

Jackson, C ;

Lewis, S ;

Liss, J ;

Mahdavi, Z ;

Rothrock, J ;

Tom, T ;

Zweifler, R .

STROKE, 1997, 28 (11) :2109-2118

[3] URGENT THERAPY FOR STROKE .1. PILOT-STUDY OF TISSUE PLASMINOGEN-ACTIVATOR ADMINISTERED WITHIN 90 MINUTES [J].

BROTT, TG ;

HALEY, EC ;

LEVY, DE ;

BARSAN, W ;

BRODERICK, J ;

SHEPPARD, GL ;

SPILKER, J ;

KONGABLE, GL ;

MASSEY, S ;

REED, R ;

MARLER, JR .

STROKE, 1992, 23 (05) :632-640

[4] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].

Hacke, W ;

Albers, G ;

Al-Rawi, Y ;

Bogousslavsky, J ;

Davalos, A ;

Eliasziw, M ;

Fischer, M ;

Furlan, A ;

Kaste, M ;

Lees, KR ;

Soehngen, M ;

Warach, S .

STROKE, 2005, 36 (01) :66-73

[5] URGENT THERAPY FOR STROKE .2. PILOT-STUDY OF TISSUE PLASMINOGEN-ACTIVATOR ADMINISTERED 91-180 MINUTES FROM ONSET [J].

HALEY, EC ;

LEVY, DE ;

BROTT, TG ;

SHEPPARD, GL ;

WONG, MCW ;

KONGABLE, GL ;

TORNER, JC ;

MARLER, JR .

STROKE, 1992, 23 (05) :641-645

[6] A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke [J].

Haley, EC ;

Lyden, PD ;

Johnston, KC ;

Hemmen, TM .

STROKE, 2005, 36 (03) :607-612

[7] PILOT RANDOMIZED TRIAL OF TISSUE-PLASMINOGEN ACTIVATOR IN ACUTE ISCHEMIC STROKE [J].

HALEY, EC ;

BROTT, TG ;

SHEPPARD, GL ;

BARSAN, W ;

BRODERICK, J ;

MARLER, JR ;

KONGABLE, GL ;

SPILKER, J ;

MASSEY, S ;

HANSEN, CA ;

TORNER, JC .

STROKE, 1993, 24 (07) :1000-1004

[8] Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits [J].

Lapchak, PA ;

Araujo, DM ;

Zivin, JA .

EXPERIMENTAL NEUROLOGY, 2004, 185 (01) :154-159

[9] A LONG-HALF-LIFE AND FIBRIN-SPECIFIC FORM OF TISSUE-PLASMINOGEN ACTIVATOR IN RABBIT MODELS OF EMBOLIC STROKE AND PERIPHERAL BLEEDING [J].

THOMAS, GR ;

THIBODEAUX, H ;

ERRETT, CJ ;

BADILLO, JM ;

KEYT, BA ;

REFINO, CJ ;

ZIVIN, JA ;

BENNETT, WF .

STROKE, 1994, 25 (10) :2072-2078

← 1 →